Cargando…
ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
Currently, there is no reliable biomarker to clinically predict the prognosis of lung adenocarcinoma (ADC). The receptor-tyrosine-kinase like orphan receptor 1 (ROR1) is reported to be overexpressed and associated with poor prognosis in several tumors. This study aimed to examine the expression of R...
Autores principales: | Zheng, Yu-Zhu, Ma, Rui, Zhou, Jian-Kang, Guo, Cheng-Lin, Wang, Yong-Sheng, Li, Zheng-Guang, Liu, Lun-Xu, Peng, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103212/ https://www.ncbi.nlm.nih.gov/pubmed/27830754 http://dx.doi.org/10.1038/srep36447 |
Ejemplares similares
-
ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer
por: Zhou, Jian-Kang, et al.
Publicado: (2017) -
Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Zeng, Zhen, et al.
Publicado: (2022) -
Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines
por: Wang, Hui-Li, et al.
Publicado: (2019) -
Functional and clinical significance of ROR1 in lung adenocarcinoma
por: Giovanna, Schiavone, et al.
Publicado: (2020) -
Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma
por: Feng, Wei, et al.
Publicado: (2023)